Beyond Prompts: The Medical Writer’s Evolving Role in Artificial Intelligence–Integrated Regulatory Writing

Abstract

Concerns that artificial intelligence (AI) will displace regulatory medical writers or reduce their role to prompt engineering persist in the field, but emerging enterprise deployments and regulatory developments suggest a more nuanced trajectory. Early enterprise implementations show AI accelerating drafting while increasing demand for validation and oversight expertise. Regulatory signals, including the Food and Drug Administration’s (FDA’s) 2025 credibility framework, joint FDA European Medicines Agency (EMA) principles, and the European Union AI Act, place account ability for AI-assisted content on sponsors and their teams. Five integrated competencies define the evolving role: technology and risk assessment, workflow design, systematic quality assurance, data literacy, and extended cross functional leadership and accountability. As routine drafting is increasingly automated, professional value in regulatory medical writing shifts toward governance, validation, and strategic oversight. These build on, rather than replace, traditional medical writing foundations.